The Wild West of AI Therapy Laws
Summary
This WSJ episode examines the patchwork of state laws restricting AI mental health chatbots, using Illinois’ ban on “AI therapy” as a case study. It explores how companies like Slingshot and Talkspace navigate these regulations by rebranding their tools or emphasizing privacy safeguards. The discussion also covers the lack of federal oversight, data privacy risks, and the FDA’s emerging role in evaluating AI as a medical device for mental health care.
Topics discussed
Intro: AI therapy bans and user impact
Defining AI therapy vs mental health tools
State laws restricting AI therapy bots
Critiques of bans and regulatory navigation
Privacy risks and data consent concerns
FDA advisory committee and pilot programs
Future integration and human-AI dynamics
Listen ad-free on Castria